Cargando…
Implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: Does it affect our patients too?
Intrachromosomal amplification (iAMP) of chromosome 21 entity is associated with a dismal outcome in B cell Acute Lymphoblastic Leukemia (B-ALL). This cytogenetic abnormality is caused by a novel mechanism; breakage-fusion-bridge cycles followed by chromothripsis along with major gross rearrangement...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589538/ https://www.ncbi.nlm.nih.gov/pubmed/31285807 http://dx.doi.org/10.4081/hr.2019.7826 |
_version_ | 1783429405615325184 |
---|---|
author | Al-Sweedan, Suleimman Altahan, Rahaf |
author_facet | Al-Sweedan, Suleimman Altahan, Rahaf |
author_sort | Al-Sweedan, Suleimman |
collection | PubMed |
description | Intrachromosomal amplification (iAMP) of chromosome 21 entity is associated with a dismal outcome in B cell Acute Lymphoblastic Leukemia (B-ALL). This cytogenetic abnormality is caused by a novel mechanism; breakage-fusion-bridge cycles followed by chromothripsis along with major gross rearrangements in chromosome 21. Charts of B-ALL diagnosed at King Faisal Specialist Hospital and Research Center between 2005 and 2015 were reviewed. iAMP is a rare entity occurring at around 2.4% of all pediatrics BALL. No statistically significant difference was found among patients with iAMP21, patients with extra copies of 21 and other patients with B-ALL. The reported adverse prognostic effect of iAMP21 could be due to other coexistent adverse factors, including older age at the time of diagnosis. The most common associated abnormality in our population in addition to the hyperdiploidy was ETV6/RUNX1. |
format | Online Article Text |
id | pubmed-6589538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-65895382019-07-08 Implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: Does it affect our patients too? Al-Sweedan, Suleimman Altahan, Rahaf Hematol Rep Article Intrachromosomal amplification (iAMP) of chromosome 21 entity is associated with a dismal outcome in B cell Acute Lymphoblastic Leukemia (B-ALL). This cytogenetic abnormality is caused by a novel mechanism; breakage-fusion-bridge cycles followed by chromothripsis along with major gross rearrangements in chromosome 21. Charts of B-ALL diagnosed at King Faisal Specialist Hospital and Research Center between 2005 and 2015 were reviewed. iAMP is a rare entity occurring at around 2.4% of all pediatrics BALL. No statistically significant difference was found among patients with iAMP21, patients with extra copies of 21 and other patients with B-ALL. The reported adverse prognostic effect of iAMP21 could be due to other coexistent adverse factors, including older age at the time of diagnosis. The most common associated abnormality in our population in addition to the hyperdiploidy was ETV6/RUNX1. PAGEPress Publications, Pavia, Italy 2019-06-14 /pmc/articles/PMC6589538/ /pubmed/31285807 http://dx.doi.org/10.4081/hr.2019.7826 Text en ©Copyright S. Al-Sweedan and R. Altahan, 2019 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Al-Sweedan, Suleimman Altahan, Rahaf Implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: Does it affect our patients too? |
title | Implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: Does it affect our patients too? |
title_full | Implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: Does it affect our patients too? |
title_fullStr | Implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: Does it affect our patients too? |
title_full_unstemmed | Implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: Does it affect our patients too? |
title_short | Implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: Does it affect our patients too? |
title_sort | implications of intrachromosomal amplification of chromosome 21 on outcome in pediatric acute lymphoblastic leukemia: does it affect our patients too? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589538/ https://www.ncbi.nlm.nih.gov/pubmed/31285807 http://dx.doi.org/10.4081/hr.2019.7826 |
work_keys_str_mv | AT alsweedansuleimman implicationsofintrachromosomalamplificationofchromosome21onoutcomeinpediatricacutelymphoblasticleukemiadoesitaffectourpatientstoo AT altahanrahaf implicationsofintrachromosomalamplificationofchromosome21onoutcomeinpediatricacutelymphoblasticleukemiadoesitaffectourpatientstoo |